POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS)

Clinical trials for POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS) explained in plain language.

Never miss a new study

Get alerted when new POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS) trials appear

Sign up with your email to follow new studies for POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Drug access extended for patients in previous trials

Disease control Ongoing

This study allows people who were already receiving itacitinib in previous clinical trials to continue taking the medication. It's for adults with myelofibrosis, chronic graft-versus-host disease, or lung transplant complications who were benefiting from the drug in earlier studi…

Matched conditions: POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS)

Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Apr 01, 2026 23:40 UTC

POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS)

Get alerted when new POSTLUNG TRANSPLANT (BRONCHIOLITIS OBLITERANS) trials appear

Drug access extended for patients in previous trials